Source: http://www.hospitalingles.com.br/transplante-medula-ossea/referencias-bibliograficas
Timestamp: 2019-04-24 14:38:52+00:00

Document:
SANTOS, G.W. History of bone marrow transplantation. Clin. Hematol. 1983;12(3):611-639.
FERREIRA, E.; DULLEY, F.L.; MORSOLETTO, F.; NETO, J.Z.; PASQUINI, R. Bone marrow transplantation in Brazil. Human Immun. 1985;14:324-332.
THOMAS, E.D.; STORB, R. Technique for human marrow grafting. Blood. 1970;36:507-515.
BUCKNER, C.D.; CLIFT, R.A.; SANDERS, J.E.; STEWART, P.; BENSINGER, W.I.; DONEY, K.C. et al. Marrow harvesting from normal donors. Blood. 1984, 64: 630-634.
ANDERLINI, P.; DONATO, M.; CHAN, K.W.; HUH, Y.O.; GEE, A.P.; LAUPPE, M.J.; CHAMPLIN, R.E.; KORBLING, M. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion. 1999;39:555-560.
GLUCKMAN, E.; BROXMEYER, H.E.; AUERBACH, A.D.; FRIEDMAN, H.S.; DOUGLAS, G.W.; DEVERGIE, A.; ESPEROU, H.; THIERRY, D.; SOCIE, G.; LEHN, P. et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from a HLA-identical sibling. N. Engl. J. Med. 1989;321:1174-1178.
CASTRO JUNIOR, C.G. Análise clínica e epidemiológica do transplante de medula óssea no Serviço de Oncologia Pediátrica do Hospital de Clínicas de Porto Alegre. Tese (mestrado). Porto Alegre. Faculdade de Medicina – Universidade Federal do Rio Grande do Sul, 2002.
RUBINSTEIN, P.; CARRIER, C.; SEARADAVOU, A.; KURTZBERG, J.; ADAMSON, J.; MIGLIACCIO, A.R. et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 1998;339:1565-1577.
HICKMAN, R.O.; BUCKNER, C.D.; CLIFT, R.A. & cols. A modified righ atrial catheter for access to the venous system in marrow transplants. Surg. Gynecol. Obstet. 1979;148:371-375.
HILL, R.S.; MAZZA, P.; AMOS, D.; BUCKNER, F.R.; APPELBAUM, F.R.; THOMAS, E.D. Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplant. 1989; 4:69-74.
STORB, R.; PRENTICE, R.L.; THOMAS, E.D. Marrow transplantation for treatment of aplastic anemia. An analysis of factor associated with graft rejection. N. Engl. J. Med. 1977;296:61-6, 1977.
LEITMAN, S.F.; HOLLAND, P.V. Irradiation of blood products. Transfusion. 1985;25(4):293-303.
DULLEY, F.L.; KANFER, E.J.; APPELBAUM, F.R. & cols. Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation. 1987;43(6):870-873.
KUPARI, M.; VOLIN, L.; SUOKAS, A. & cols. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhytmias, heart failure and autopsy findings. Bone Marrow Transplant. 1990;5:91-98.
HAMILTON, P.J. & PEARSON, A.D.J. Bone marrow transplantation and the lung. Thorax. 1986;41: 497-502.
MIRALBELL, R.; BIERI, S.; MERMILLOD, B.; HELG, C.; SANCHO, G.; PASTOORS, B.; KELLER, A.; KURTZ, J.M.; CHAPUIS, B. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J. Clin. Oncol. 1996 Feb; 14(2): 579-85.
JUNE, C.H.; THOMPSON, C.B.; KENNEDY, M.S. & cols. Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients. Transplantation, 41(1): 47-51, 1986.
REECE, D.E.; FREI-LAHR, D.A.; SHEPHERD, J.D. & cols. Neurologic complications in allogeneic bone marrow transplants patients receiving ciclosporine. Bone Marrow Transplant., 8:393-401, 1991.
WINGARD, J.R. Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow Transplant. v. 6, p. 371-83, 1990.
SABOYA, R. Infecções bacterianas e fúngicas no transplante de medula óssea – análise de 186 pacientes. 254 p. Tese (doutorado). São Paulo: Faculdade de Medicina – Universidade de São Paulo, 1998.
PETERSDORF, R.; BEESON, P. Fever of unexplained origin: Report of 100 cases. Medicine. v. 40, p.1, 1961.
CUNHA, C.A.; WEISDORF, D.; SHU, X.O.; DEFOR, T.; PASTOR III, J.D.; JOHNSON, J.R. Early Gram positive bacteremia in BMT recipients: Impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant. v. 21; p. 173-8, 1998.
SULLIVAN, K.M.; DEEG, H.J.; SANDERS, J.E. Late complications after marrow transplantation. Semin Hematol. v. 21, p. 53-63, 1984.
FERRARA, J.L.M.; DEEG, H.J. Graft-versus-host disease. N. Engl. J. Med. v. 324, p. 667-74, 1991.
GLUCKSBERG, H.; STORB, R.; FEFER, A. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation. v. 18, p. 295-304, 1974.
VOGELSANG, G.B.; HESS, A.D.; SANTOS, G.W. Acute graft-versus-host disease clinical characteristics in the cyclosporine era. Medicine. v. 67, p. 163-74, 1988.
PERTERS, C.; MINKOV, M.; GADNER, H.; KLINGEBIEL, T.; VOSSEN, J. LOCATELLI, F. et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant. 2000, 26: 405-411.
HOROWITZ, M.M.; GALE, R.P.; SONDEL, P.M.; GOLDMAN, J.M.; KERSEY, J.; KOLB, H.J. et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990, 75: 555-562.
SLAVIN, S. NAGLER, A. Immune adjuvant therapy post high dose therapy. In High dose cancer therapy. Pharmacology, Hematopoietins, Stem Cells. Ed. Armitage J.O.; Antman, K.H. 3rd. Philadelphia – EUA. 2000, Lippincott & Wilkins 123-137.
JACOBSOM, D.A. and VOGELSANG, G.B. Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. Drugs. 2002: 62(6), 879-889.
DROSOS, A.A. Newer immunosuppressive drugs. Their potential role in rheumatoid arthritis therapy. Drugs. 2002: 62(6), 891-907.
SULLIVAN, K.M.; AGURA, E.; ANASETTI, C.; BUCKNER, D. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin. Hematol. v. 28, p. 250-9, 1991.
DEEG, H.J. Delayed complications after hematopoietic cell transplantation. In Hematopoietic Cell Transplantation. THOMAS, E.D.; 2nd ed. EUA. 1999. Blackwell Science, INC. 776-788.
DULLEY, F.L. Bussulfano e ciclofosfamida como condicionamento para o transplante de medula óssea da anemia aplástica grave. Tese de Livre docência. 99 p. São Paulo: Faculdade de Medicina – Universidade de São Paulo. 2000.
Pavletic S.Z, Martin P, Lee SF, Mitchell S, Jacobsohn D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Shubert M, Berger A, Bross P, Chien FW, Couriel D, Dunn FP, Fall-Dickson F, Farrel A, Flowers MED, Greinix H, Hirsshfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA, Miller FW, Mittleman B, Papadopoulos E, Parsons SK, Przepiorka D, Robinson M, Ward M, Reeve B, Rider LG, Shulman H, Schultz KR, Weisdorf D, Vogelsang GB. Measuring therapeutic response in chronic graft-versus-host diasease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation. Bone Marrow Transplantation, 2006;12:252-266.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard FR, Lee SF, Martin P, Chien F, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey F, Jacobsohn D, Mc Donald G, Mittleman B, Rizzo FD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogesang G, Flowers MED. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host disease: I. Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation . Bone marrow transplantation. 2005;11:945-955.
Martin PF, Weisdorf D, Przepiork D, Hirschfeld S, Farrell A, Rizzo FD, Foley R, Socie G, Carter S, Couriel D, Schultz KR, Flowers MED, Filipovich AH, Saliba R, Vogelsang GB, Pavletic SZ, Lee SF. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host disease: VI. Design of Clinical Trials Working Group Report. Biology of Blood and Marrow Transplantation. Bone marrow transplantation; 2006;12:491-505.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.